COVID19 Alert Several meetings are now virtual or rescheduled Check the calendar
COVID19 Alert Several meetings are now virtual or rescheduled Check the calendar
1. J Cutan Aesthet Surg. 2020 Apr-Jun;13(2):77-94. doi: 10.4103/JCAS.JCAS_83_20.
Recommendations for Cutaneous and Aesthetic Surgeries during COVID-19 Pandemic.
Mysore V(1), Savitha AS(2), Venkataram A(1), Inamadar AC(3), Sanjeev A(4),
Byalekere Chandrashekar S(5), Devaraj DK(6), Khunger N(7), Reddy RR(2), Rashi
P(8), Salim T(9), Mutalik SD(10), Arsiwala S(11)(12)(13), Barua S(14), Gupta
S(8), Sirur S(15), Shah S(16).
Author information:
(1)The Venkat Center for Skin ENT & Plastic Surgery, Bengaluru, India.
(2)Department of Dermatology, Sapthagiri Institute of Medical Sciences and
Research Centre, Bangalore, India.
(3)Department of Dermatology, Sri B M Patil Medical College Hospital and
Research Centre, BLDE University, Vijayapura, Karnataka, India.
(4)Skin & Laser Clinic, Hyderabad, Telangana, India.
(5)CUTIS Academy of Cutaneous Sciences, Bengaluru, Karnataka, India.
(6)Dr. Dinesh's Skin & Hair Clinic, Chennai, Tamil Nadu, India.
(7)Department of Dermatology, Vardhaman Mahavir Medical College, Safdarjang
Hospital, New Delhi, India.
(8)Department of Dermatology and Venereology, All India Institute of Medical
Sciences, New Delhi, India.
(9)Cutis Institute, Calicut, Kerala, India.
(10)Department of Dermatology, Maharashtra Medical Foundation, Pune, India.
(11)Renewderm Centre, Mumbai, Maharashtra, India.
(12)Saifee Hospital, Mumbai, Maharashtra, India.
(13)Prince Aly Khan Hospital, Mumbai, Maharashtra, India.
(14)Department of Dermatology, Assam Medical College & Hospital, Dibrugarh,
Assam, India.
(15)Wockhardt Hospital and Apollo Spectra Hospital, Mumbai, India.
(16)Department of Dermatology, Ashwini Rural Medical College, Solapur,
Maharashtra, India.
BACKGROUND: Amid the coronavirus disease 2019 (COVID-19) pandemic,
dermatologists must be prepared to restructure their practice of procedural
dermatology and cutaneous aesthetic surgeries. The COVID-19 pandemic has
presented several challenges and has ushered in several changes in practice such
as teledermatology, with many physicians adopting virtual consultations and
treatments. Performing procedures in the times of COVID-19 pandemic presents
challenges such as risk of transmission to doctors and staff due to potential
aerosolization, release of virus droplets during the procedures, and risk of
virus transfer through the instruments both in the peri- and postoperative
period. This can have several medical, administrative, and legal implications.
OBJECTIVES: This document aimed to outline best practices that can be followed
in this scenario to perform cutaneous surgeries and procedures to ensure safer
skin surgery.
RECOMMENDATIONS: Standard precautions include social distancing of at least 1 m,
hand hygiene, appropriate use of personal protective equipment (PPE), safe
injection practices, sterilization and disinfection of medical devices,
environmental cleaning, and respiratory hygiene. It is generally advisable to
see patients only by appointments. Each clinic should have a special area at
entry for screening patients and providing sanitizers and masks. Procedures,
which are of short duration, performed on nonfacial areas are considered as low
risk and require donning surgical mask. Procedures involved with minimal
invasiveness and bleeding, short duration procedures on the face such as
injectables, chemical peels, and aerosol-generating procedures on nonfacial
areas are considered moderate risk. These procedures need apron with head cover,
N95 mask, face shield, double gloves, and smoke evacuator with high-efficiency
particulate air (HEPA) or ultralow particulate air (ULPA) filter. Aerosol and
plume-regenerating procedures (such as ablative lasers on the face), prolonged
surgeries on head (such as hair transplantation), intraoral, and intranasal
procedures are considered high risk. These procedures must be carried out with
full body cover with surgical gown, head cover, N95 mask, face shield, double
gloves, and smoke evacuator. Physicians should be aware of local epidemiological
situation and adhere to the relevant guidelines issued by the relevant
governmental agencies.
Copyright: © 2020 Journal of Cutaneous and Aesthetic Surgery.
DOI: 10.4103/JCAS.JCAS_83_20
PMCID: PMC7394118
PMID: 32792769
Conflict of interest statement: There are no conflicts of interest.
2. Arch Dermatol Res. 2020 Aug 12. doi: 10.1007/s00403-020-02119-5. Online ahead of
print.
Patient education in Mohs surgery: a review and critical evaluation of
techniques.
Patel P(1), Malik K(2), Khachemoune A(3)(4).
Author information:
(1)Division of Dermatology, Department of Medicine, Montefiore Medical Center,
Albert Einstein College of Medicine, Bronx, New York, USA.
(2)Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York,
USA.
(3)Department of Dermatology, SUNY Downstate, Brooklyn, New York, USA.
(4)Dermatology Service, Veterans Affairs Hospital, SUNY Downstate, 800 Poly
Place Brooklyn, New York, 11209, USA. amorkh@gmail.com.
BACKGROUND: Traditional in-person discussion alone is often used for
preoperative education in Mohs micrographic surgery (MMS). The appropriate use
of more modern education techniques is not well defined in the MMS literature.
OBJECTIVE: The authors aim to evaluate patient education techniques for MMS,
address education in special populations, and highlight opportunities for
improvement.
METHODS AND MATERIALS: We performed a PubMed literature search with keywords
"Mohs" and "education", "teaching", "understanding", "explanation",
"preoperative", or "consent" with no restriction on publication time frame due
to literature scarcity.
RESULTS: Teledermatology consultation, MMS videos, 3D models, pamphlets/online
materials, and shared medical appointments appear to be effective techniques
(GRADE B). Analogies are also anecdotally helpful when integrated into
traditional verbal education (GRADE C). The role of preoperative educational
phone calls is more controversial (GRADE C).
CONCLUSION: Regardless of the education technique utilized, no singular
technique entirely replaces the traditional in-person discussion. Having access
to multiple modalities can be beneficial for patients, allowing them options to
choose their preferred method(s) of education. MMS is a difficult topic to
conceptualize, and further research into educational techniques is needed to
provide clear guidelines for Mohs surgeons.
DOI: 10.1007/s00403-020-02119-5
PMID: 32785836
3. J Dermatolog Treat. 2020 Aug 12:1-7. doi: 10.1080/09546634.2020.1809625. Online
ahead of print.
Psychological teleconsultations in patients suffering from chronic skin diseases
during the COVID-19 era: a service to improve patients' quality of life.
Marasca C(1), De Rosa A(1), Fabbrocini G(1), Cantelli M(1), Patrì A(1),
Vastarella M(1), Gallo L(1), di Vico F(1), Poggi S(1), Ruggiero A(1).
Author information:
(1)Department of Clinical Medicine and Surgery, Section of Dermatology,
University of Naples Federico II, Naples, Italy.
The COVID-19 era represented an important stressful event affecting population
in many different ways, with important negative impact on social, working and
relational life. Indeed, the home-isolation in addition to the high-level of
distress given by fear of infection, has significantly resulted in a large
number of psychological-consequences. Moreover, in order to guarantee a
continuity of care, different measures have been applied among hospitals such as
the implementation of teledermatology services. For these reasons, we
implemented at our Dermatological-Clinic psychological video-consultations
through our teledermatology-services. Herein we report our experience of 23
psychological-video-consultations, which led to achieve a significant reduction
of DLQI (from 4.4 ± 3.9 at baseline to 1.6 ± 2.5 at week-4) in patients
suffering from chronic skin conditions during the COVID-19 era.
DOI: 10.1080/09546634.2020.1809625
PMID: 32783664
4. J Am Acad Dermatol. 2020 Aug 8:S0190-9622(20)32373-2. doi:
10.1016/j.jaad.2020.08.016. Online ahead of print.
Telemedicine and the battle for health equity: Translating temporary regulatory
orders into sustained policy change.
Kassamali B(1), Haddadi NS(2), Rashighi M(2), Cavanaugh-Hussey M(3), LaChance
A(4).
Author information:
(1)Harvard Medical School, Boston, Massachusetts; Department of Dermatology,
Brigham and Women's Hospital, Boston, Massachusetts.
(2)Department of Dermatology, University of Massachusetts School of Medicine,
Worchester, Massachusetts.
(3)Department of Dermatology, Brigham and Women's Hospital, Boston,
Massachusetts; Harvard Medical School, Boston, Massachusetts.
(4)Department of Dermatology, Brigham and Women's Hospital, Boston,
Massachusetts; Harvard Medical School, Boston, Massachusetts. Electronic
address: alachance@bwh.harvard.edu.
DOI: 10.1016/j.jaad.2020.08.016
PMCID: PMC7414778
PMID: 32781185
5. J Am Acad Dermatol. 2020 Aug 6:S0190-9622(20)32356-2. doi:
10.1016/j.jaad.2020.07.119. Online ahead of print.
'Drop dermoscopy' for teledermatology.
Kaliyadan F(1), Jayasree P(2), Ashique KT(3).
Author information:
(1)European Board Dermatovenereology, FRCP (London) Faculty of Dermatology,
College of medicine, King Faisal University, Saudi Arabia. Electronic address:
(2)Consultant Dermatologist, Medical Trust Hospital, Cochin, Kerala, India.
(3)Medical Director & Senior Consultant Dermatologist Amanza Health Care,
Perinthalmanna, 679322. Kerala. India College of medicine, King Faisal
University, Al-Ahsa ,Saudi Arabia.
DOI: 10.1016/j.jaad.2020.07.119
PMCID: PMC7410012
PMID: 32771542
6. Dermatol Ther. 2020 Aug 8:e14161. doi: 10.1111/dth.14161. Online ahead of print.
Mental Distress in Dermatologists During COVID-19 Pandemic: Assessment and Risk
Factors in A Global, Cross-Sectional Study.
Bhargava S(1), Sarkar R(2), Kroumpouzos G(3)(4)(5).
Author information:
(1)Department of Dermatology, R.D. Gardi Medical College, Ujjain, India.
(2)Department of Dermatology, Lady Hardinge Medical College, New Delhi, India.
(3)Department of Dermatology, Alpert Medical School of Brown University,
Providence, RI, USA.
(4)Department of Dermatology, Medical School of Jundiaí, São Paulo, Brazil.
(5)GK Dermatology, PC, South Weymouth, MA, USA.
BACKGROUND: There is a sparsity of data regarding the mental health status of
dermatologists during COVID-19 pandemic.
OBJECTIVES: Evaluate the effects of pandemic on mental health of dermatologists
on a large scale and identify risk factors for mental distress.
METHODS: 733 dermatologists were included in this cross-sectional, web-based
survey.
RESULTS: Mental distress was reported by 77.2% of responders. Considerable
percentages of participants experienced stress (73.9%), irritation (33.7%),
insomnia (30%), or depression (27.6%), and 78.6% were overwhelmed with the
amount of pandemic information they were receiving. Mental distress was
significantly associated with practice years, volume of patients seen per week
before pandemic, personal protective equipment availability at hospital (P=.001
for each), practice location (continent) (P <.001), and participant's assessment
that the healthcare system was not equipped for the pandemic (P=.003). Stress
was associated with hospital service (P=.003), and depression with being
overwhelmed with the amount of pandemic information received (P=.004). In a
logistic model, teledermatology use was the most powerful predictor of mental
distress (OR, 1.57 [95% CI, 1.07-2.32]).
CONCLUSIONS: Mental distress was common among dermatologists during this
pandemic. Teledermatology use was the most powerful predictor of mental
distress. Preventative strategies and psychosocial interventions should be
implemented. This article is protected by copyright. All rights reserved.
This article is protected by copyright. All rights reserved.
DOI: 10.1111/dth.14161
PMID: 32770716
7. J Ultrasound Med. 2020 Aug 7. doi: 10.1002/jum.15409. Online ahead of print.
Dermatologic Ultrasound in Primary Care: A New Modality of Teledermatology: A
Prospective Multicenter Validation Study.
Alfageme F(1), Minguela E(2), Martínez C(1), Salgüero I(1), Calvo A(3), León
F(4), Álvarez L(4), de Vicente O(5), Panadero FJ(6), Salguero OL(7), Roustán
G(1).
Author information:
(1)Dermatology Department, Hospital Universitario Puerta de Hierro Majadahonda,
Madrid, Spain.
(2)Centro de Salud Valle de la Oliva Majadahonda, Madrid, Spain.
(3)Centro de Salud de Galapagar, Madrid, Spain.
(4)Centro de Salud San Juan de la Cruz, Pozuelo de Alarcón, Spain.
(5)Centro de Salud La Marazuela, Las Rozas, Spain.
(6)Centro de Salud Villanueva de la Cañada, Madrid, Spain.
(7)Centro de Salud Cerro del Aire Majadahonda, Madrid, Spain.
OBJECTIVES: This study aimed to validate dermatologic ultrasound as a
complementary teledermatologic imaging modality in primary and tertiary care
centers.
METHODS: Six primary care centers and 1 tertiary care dermatology department
collaborated in the program. Images were sent through the institutional
teledermatologic platform to the tertiary care dermatology department. At the
reference hospital, ultrasound images and clinical data were received and
registered by a physician trained in dermatologic ultrasound. An in-person
consultation was scheduled to confirm the teleultrasound diagnosis. The time of
response by the tertiary center, quality and size of the teledermatologic image,
and concordance with the in-person diagnosis were assessed for each dermatologic
lesion.
RESULTS: A total of 147 teleultrasound consultations with 143 patients (93 women
and 50 men; mean age ± SD, 47 ± 23 years) were evaluated between June 2018 and
January 2019. Nine teleultrasound consultations (6.1%) were not valid.
Discordance between teleultrasound and the in-person diagnosis was evident in 6
of 138 cases (4.3%). Most cases corresponded to benign skin tumors (66.7%),
followed by inflammatory skin lesions (15.9%), nonmelanoma skin lesions (13%),
and other skin lesions (4.3%). All malignant tumors were detected (sensitivity,
100%), although 2 cases of benign lesions were telediagnosed as malignant
(specificity, 97.8%). The positive and negative predictive values of a
teleultrasound diagnosis of cutaneous malignancy were 90% and 100%,
respectively.
CONCLUSIONS: Asynchronous primary care teleultrasound combined with dermatologic
ultrasound training at tertiary centers is an effective teledermatologic
modality.
© 2020 American Institute of Ultrasound in Medicine.
DOI: 10.1002/jum.15409
PMID: 32767579
8. Dermatol Ther. 2020 Aug 6:e14149. doi: 10.1111/dth.14149. Online ahead of print.
COVID-19: An Opportunity to Build Dermatology's Digital Future.
Puri P(1)(2), Comfere N(2)(3), Pittelkow MR(2)(4), Bezalel SA(2)(3), Murphree
DH(2)(5).
Author information:
(1)Mayo Clinic Alix School of Medicine, Scottsdale, AZ.
(2)Mayo Clinic Office of Artificial Intelligence in Dermatology.
(3)Department of Dermatology, Mayo Clinic, Rochester, MN.
(4)Depatment of Dermatology, Mayo Clinic, Scottsdale, AZ.
(5)Department of Health Sciences Research, Mayo Clinic, Rochester, MN.
DOI: 10.1111/dth.14149
PMID: 32767453
9. Hautarzt. 2020 Aug 6:1-5. doi: 10.1007/s00105-020-04664-6. Online ahead of
print.
[Artificial intelligence to support telemedicine in Africa].
[Article in German]
Greis C(1), Maul LV(2), Hsu C(2), Djamei V(3), Schmid-Grendelmeier P(3),
Navarini AA(2).
Author information:
(1)Klinik für Dermatologie, Universitätsspital Zürich, Gloriastr. 31, 8091,
Zürich, Schweiz. christian.greis@usz.ch.
(2)Klinik für Dermatologie, Universitätsspital Basel, Basel, Schweiz.
(3)Klinik für Dermatologie, Universitätsspital Zürich, Gloriastr. 31, 8091,
Zürich, Schweiz.
Telemedicine has been used in the daily routine of dermatologists for decades.
The potential advantages are especially obvious in African countries having
limited medical care, long geographical distances, and a meanwhile relatively
well-developed telecommunication sector. National and international working
groups support the establishment of teledermatological projects and in recent
years have increasingly been using artificial intelligence (AI)-based
technologies to support the local physicians. Ethnic variations represent
a challenge in the development of automated algorithms. To further improve the
accuracy of the systems and to be able to globalize, it is important to increase
the amount of available clinical data. This can only be achieved with the active
participation of local health care providers as well as the dermatological
community and must always be in the interest of the individual patient.
Telemedizin findet seit Jahrzehnten Anwendung im Alltag von Dermatologen.
Insbesondere in afrikanischen Ländern mit begrenzter medizinischer Versorgung,
zu überbrückenden geografischen Distanzen und einem zwischenzeitlich relativ gut
ausgebauten Telekommunikationssektor liegen die Vorteile auf der Hand. Nationale
und internationale Arbeitsgruppen unterstützen den Aufbau von
teledermatologischen Projekten und bedienen sich in den letzten Jahren zunehmend
KI(künstliche Intelligenz)-gestützter Technologien, um Ärzte vor Ort zu
unterstützen. Vor diesem Hintergrund stellen ethnische Variationen eine
besondere Herausforderung in der Entwicklung automatisierter Algorithmen dar. Um
die Genauigkeit der Systeme weiter zu verbessern und globalisieren zu können,
ist es wichtig, die Zahl der verfügbaren klinischen Daten zu erhöhen. Dies kann
nur mit der aktiven Beteiligung der lokalen Gesundheitsversorger sowie der
dermatologischen Gemeinschaft gelingen und muss stets im Interesse des einzelnen
Patienten erfolgen.
DOI: 10.1007/s00105-020-04664-6
PMCID: PMC7407433
PMID: 32761386
10. Contact Dermatitis. 2020 Aug 4. doi: 10.1111/cod.13683. Online ahead of print.
Teledermatology and hygiene practices during the COVID-19 pandemic.
Cristaudo A(1), Pigliacelli F(1), Pacifico A(1), Damiani G(2), Iacovelli P(1),
Morrone A(1).
Author information:
(1)San Gallicano Dermatological Institute IRCCS, Rome, Italy.
(2)Clinical Dermatology, Department of Biomedical, Surgical and Dental Sciences,
IRCCS Galeazzi, Orthopaedic Institute, University of Milan, 20126, Milan, Italy.
DOI: 10.1111/cod.13683
PMID: 32754901
1. JMIR Public Health Surveill. 2020 Apr 2;6(2):e18810. doi: 10.2196/18810.
Global Telemedicine Implementation and Integration Within Health Systems to
Fight the COVID-19 Pandemic: A Call to Action.
Ohannessian R(1), Duong TA(2)(3), Odone A(4)(5)(6).
Author information:
(1)Télémédecine 360, TLM360, Paris, France.
(2)Dermatology Department, AP-HP, Henri Mondor Hospital, Créteil, France.
(3)Chaire Avenir Sante numérique, équipe 8 IMRB, Inserm, Créteil, France.
(4)School of Public Health, Faculty of Medicine, University Vita-Salute San
Raffaele, Milan, Italy.
(5)Clinical Epidemiology and HTA, IRCCS San Raffaele Scientific Institute,
Milan, Italy.
(6)Digital Health Section, European Public Health Association, Milan, Italy.
On March 11, 2020, the World Health Organization declared the coronavirus
disease 2019 (COVID-19) outbreak as a pandemic, with over 720,000 cases reported
in more than 203 countries as of 31 March. The response strategy included early
diagnosis, patient isolation, symptomatic monitoring of contacts as well as
suspected and confirmed cases, and public health quarantine. In this context,
telemedicine, particularly video consultations, has been promoted and scaled up
to reduce the risk of transmission, especially in the United Kingdom and the
United States of America. Based on a literature review, the first conceptual
framework for telemedicine implementation during outbreaks was published in
2015. An updated framework for telemedicine in the COVID-19 pandemic has been
defined. This framework could be applied at a large scale to improve the
national public health response. Most countries, however, lack a regulatory
framework to authorize, integrate, and reimburse telemedicine services,
including in emergency and outbreak situations. In this context, Italy does not
include telemedicine in the essential levels of care granted to all citizens
within the National Health Service, while France authorized, reimbursed, and
actively promoted the use of telemedicine. Several challenges remain for the
global use and integration of telemedicine into the public health response to
COVID-19 and future outbreaks. All stakeholders are encouraged to address the
challenges and collaborate to promote the safe and evidence-based use of
telemedicine during the current pandemic and future outbreaks. For countries
without integrated telemedicine in their national health care system, the
COVID-19 pandemic is a call to adopt the necessary regulatory frameworks for
supporting wide adoption of telemedicine.
©Robin Ohannessian, Tu Anh Duong, Anna Odone. Originally published in JMIR
Public Health and Surveillance (http://publichealth.jmir.org), 02.04.2020.
DOI: 10.2196/18810
PMCID: PMC7124951
PMID: 32238336 [Indexed for MEDLINE]
Conflict of interest statement: Conflicts of Interest: None declared.
2. Med Leg J. 2020 Jun 3:25817220926926. doi: 10.1177/0025817220926926. Online
ahead of print.
Telemedicine during Covid-19 pandemic: Advantage or critical issue?
Perrone G(1), Zerbo S(1), Bilotta C(1), Malta G(1), Argo A(1).
Author information:
(1)Department of Health Promotion, Maternal and Child Care, "G. D'Alessandro",
Legal Medicine Section, University of Palermo, Palermo, Italy.
Telemedicine offers a support to traditional medicine, delivering clinical
services when distance is a critical factor. Although this tool does not replace
a medical examination, during Covid-19 pandemic, it reduces the spread of
infection and avoids the need for a patient's visit. It is useful in the
management of chronic disorders or for patients undergoing palliative treatment.
The University Hospital of Palermo has applied this in cases of chronic illness
caring for patients who cannot stop their treatment, such as Department of
Onco-Haematology, Internal Medicine, Dermatology, etc. The Department of Legal
Medicine of Palermo, in particular, is also using telemedicine to manage
medico-legal sudden natural death investigations and dealing with the Public
Prosecutor's office of Palermo. Even after the Covid-19 emergency, telemedicine
will be essential to streamline outpatient visits, while at the same time
limiting costs, with significant benefits for the Italian National Public Health
Service budget. In conclusion, telemedicine can offer a valuable support to the
doctor's activity by streamlining and facilitating their work. In this sense,
the Covid-19 pandemic represents a positive input for the acceleration and
enhancement of these tools.
DOI: 10.1177/0025817220926926
PMID: 32490720
3. J Coll Physicians Surg Pak. 2020 Apr;30(4):349-350. doi:
10.29271/jcpsp.2020.04.349.
Telemedicine in the Time of COVID-19 Pandemic.
Gondal KM(1), Shaukat S(2).
Author information:
(1)Department of Surgery, King Edward Medical University, Lahore, Pakistan.
(2)Department of Dermatology, Unit - I, King Edward Medical University, Lahore,
Pakistan.
Null.
DOI: 10.29271/jcpsp.2020.04.349
PMID: 32513349 [Indexed for MEDLINE]
4. J Dermatolog Treat. 2020 May 13:1-2. doi: 10.1080/09546634.2020.1762844. Online
ahead of print.
The danger of neglecting melanoma during the COVID-19 pandemic.
Gomolin T(1), Cline A(2), Handler MZ(2).
Author information:
(1)New York Medical College School of Medicine, Valhalla, NY, USA.
(2)Department of Dermatology, Metropolitan Hospital, New York, NY, USA.
Due to the COVID-19 pandemic, planned medical and surgical activities are being
postponed. For the dermatology community, this interruption to the healthcare
system can lead to delays in the diagnosis and treatment of melanoma. Neglecting
melanoma during this crisis can result in increased mortality, morbidity and
healthcare costs. With the COVID-19 pandemic evolving and no clear solutions in
sight, it is time for the prospective evaluation of teledermatology. However,
dermatologists should be cautious and continue seeing patients with pigmented
lesions in person due to the necessity of early surgical intervention.
DOI: 10.1080/09546634.2020.1762844
PMID: 32347761
5. J Eur Acad Dermatol Venereol. 2020 May 18:10.1111/jdv.16636. doi:
10.1111/jdv.16636. Online ahead of print.
Chilblain acral lesions in the COVID-19 era. Are they marker of infection in
asymptomatic patients?
Ramondetta A(1), Panzone M(1), Dapavo P(1), Ortoncelli M(1), Giura MT(1),
Licciardello M(1), Rozzo G(1), Siliquini N(1), Fierro MT(1), Ribero S(1).
Author information:
(1)Dermatology Clinic, University of Turin, Turin, Italy.
During these months in which the COVID‐19 emergency is waning, the activity of
dermatologists has changes substantially. Since the beginning of March 2020, in
the Dermatology Clinic at the University Hospital in Turin (Italy) the
outpatient access has been significantly reduced and telemedicine has been
useful whenever possible, by putting the patient in contact directly with
dermatologists or mediated by the general practitioners.
DOI: 10.1111/jdv.16636
PMCID: PMC7276754
PMID: 32421876
6. Pediatr Dermatol. 2020 Apr 16:10.1111/pde.14196. doi: 10.1111/pde.14196. Online
ahead of print.
Management of infantile hemangiomas during the COVID pandemic.
Frieden IJ(1), Püttgen KB(2), Drolet BA(3), Garzon MC(3), Chamlin SL(4), Pope
E(5), Mancini AJ(4), Lauren CT(6), Mathes EF(1), Siegel DH(7), Gupta D(8),
Haggstrom AN(9), Tollefson MM(10), Baselga E(11), Morel KD(6), Shah SD(1),
Holland KE(7), Adams DM(12), Horii KA(13), Newell BD(13), Powell J(14), McCuaig
CC(14), Nopper AJ(13), Metry DW(15), Maguiness S(16); Hemangioma Investigator
Group.
Author information:
(1)University of California San Francisco, San Francisco, California, USA.
(2)Intermountain Healthcare, Salt Lake City, Utah, USA.
(3)School of Medicine and Public Health, University of Wisconsin, Madison,
Wisconsin, USA.
(4)Ann & Robert H. Lurie Children's Hospital of Chicago/Northwestern University
Feinberg School of Medicine, Chicago, Illinois, USA.
(5)The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada.
(6)Columbia University Vagelos College of Physicians and Surgeons, New York, New
York, USA.
(7)Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
(8)Seattle Children's Hospital, University of Washington School of Medicine,
Seattle, Washington, USA.
(9)Indiana University, Indianapolis, Indiana, USA.
(10)Mayo Clinic, Rochester, Minnesota, USA.
(11)Hospital Sant Joan de Deu, Barcelona, Spain.
(12)Harvard Medical School, Boston, Massachusetts, USA.
(13)University of Missouri - Kansas City, Kansas City, Missouri, USA.
(14)Division of Pediatric Dermatology, Department of Pediatrics, Sainte-Justine
University Hospital Centre, University of Montreal, Montreal, QC, Canada.
(15)Baylor College of Medicine, Houston, Texas, USA.
(16)University of Minnesota, Minneapolis, Minnesota, USA.
The COVID-19 pandemic has caused significant shifts in patient care including a
steep decline in ambulatory visits and a marked increase in the use of
telemedicine. Infantile hemangiomas (IH) can require urgent evaluation and risk
stratification to determine which infants need treatment and which can be
managed with continued observation. For those requiring treatment, prompt
initiation decreases morbidity and improves long-term outcomes. The Hemangioma
Investigator Group has created consensus recommendations for management of IH
via telemedicine. FDA/EMA-approved monitoring guidelines, clinical practice
guidelines, and relevant, up-to-date publications regarding initiation and
monitoring of beta-blocker therapy were used to inform the recommendations.
Clinical decision-making guidelines about when telehealth is an appropriate
alternative to in-office visits, including medication initiation, dosage
changes, and ongoing evaluation, are included. The importance of communication
with caregivers in the context of telemedicine is discussed, and online
resources for both hemangioma education and propranolol therapy are provided.
© 2020 Wiley Periodicals, LLC.
DOI: 10.1111/pde.14196
PMCID: PMC7262142
PMID: 32298480
Conflict of interest statement: Ilona J. Frieden is a member of Venthera Medical
Advisory Board; Other: Pfizer (Data Safety Monitoring Board and investigator
NCT02913612 Pediatric Trials Network‐NIH Efficacy, Safety and Pharmacokinetics
of Topical Timolol in Infants With Infantile Hemangioma (IH) (TIM01) Beth A.
Drolet reports an investigator‐initiated trial funded by Pierre Fabre, Venthera
consultant and medical advisory, and founder of Peds Derm Development, LLC and
investigator NCT02913612 Pediatric Trials Network‐NIH Efficacy, Safety and
Pharmacokinetics of Topical Timolol in Infants With Infantile Hemangioma (IH)
(TIM01). Maria C. Garzon MD is an investigaror NCT02913612 Pediatric Trials
Network‐NIH Efficacy, Safety and Pharmacokinetics of Topical Timolol in Infants
With Infantile Hemangioma (IH) (TIM01). Sarah L. Chamlin MD is an investigator
NCT02913612 Pediatric Trials Network‐NIH Efficacy, Safety and Pharmacokinetics
of Topical Timolol in Infants With Infantile Hemangioma (IH) (TIM01). Other:
Sarah L. Chamlin MD is a consultant in Regeneron and Sanofi. Elena Pope MD
investigator in Pierre Fabre. Dawn H. Siegel MD is reviewer in ArQule (expert
reviewer) and investigator NCT02913612 Pediatric Trials Network‐NIH Efficacy,
Safety and Pharmacokinetics of Topical Timolol in Infants With Infantile
Hemangioma (IH) (TIM01). Deepti Gupta MD has no conflicts of interest to
declare. Anita N. Haggstrom MD is investigator NCT02913612 Pediatric Trials
Network‐NIH Efficacy, Safety and Pharmacokinetics of Topical Timolol in Infants
With Infantile Hemangioma (IH) (TIM01), Anthony J. Mancini MD is an investigator
NCT02913612 Pediatric Trials Network‐NIH Efficacy, Safety and Pharmacokinetics
of Topical Timolol in Infants With Infantile Hemangioma (IH) (TIM01), Megha M.
Tollefson MD is an investigator NCT02913612 Pediatric Trials Network‐NIH
Efficacy, Safety and Pharmacokinetics of Topical Timolol in Infants With
Infantile Hemangioma (IH) (TIM01), Christine T. Lauren MD is an investigator
NCT02913612 Pediatric Trials Network‐NIH Efficacy, Safety and Pharmacokinetics
of Topical Timolol in Infants With Infantile Hemangioma (IH) (TIM01), Erin F.
Mathes MD is an investigator NCT02913612 Pediatric Trials Network‐NIH Efficacy,
Safety and Pharmacokinetics of Topical Timolol in Infants With Infantile
Hemangioma (IH) (TIM01). Eulalia Baselga MD is a consultant and advisory board
member in Pierre Fabre, Venthera co‐founder and medical advisor. Kristen E.
Holland MD is an investigator NCT02913612 Pediatric Trials Network‐NIH Efficacy,
Safety and Pharmacokinetics of Topical Timolol in Infants With Infantile
Hemangioma (IH) (TIM01); Other: Kristen E. Holland MD is an investigator and
consultant in Pfizer, consultant in Regeneron, and investigator in Celgene and
Sanofi. Denise M. Adams MD is an advisory board member in Venthera and Novartis.
Katherine B. Püttgen MD is an investigator NCT02913612 Pediatric Trials
Network‐NIH Efficacy, Safety and Pharmacokinetics of Topical Timolol in Infants
With Infantile Hemangioma (IH) (TIM01), Kimberly A. Horii MD is an investigator
NCT02913612 Pediatric Trials Network‐NIH Efficacy, Safety and Pharmacokinetics
of Topical Timolol in Infants With Infantile Hemangioma (IH) (TIM01), Kimberly
D. Morel MD, is an investigator NCT02913612 Pediatric Trials Network‐NIH
Efficacy, Safety and Pharmacokinetics of Topical Timolol in Infants With
Infantile Hemangioma (IH) (TIM01), Kimberly A. Horii MD is an investigator
NCT02913612 Pediatric Trials Network‐NIH Efficacy, Safety and Pharmacokinetics
of Topical Timolol in Infants With Infantile Hemangioma (IH) (TIM01), Brandon D.
Newell MD, Catherine C. McCuaig, Amy J. Nopper MD, Denise W. Metry MD, Sheilagh
Maguiness and Sonal D. Shah MD have no conflicts of interest to declare. Julie
Powell MD is a member of advisory board and speaker in Pierre‐Fabre Dermatology.
7. Dermatol Ther. 2020 Apr 29:e13472. doi: 10.1111/dth.13472. Online ahead of
print.
Changing paradigms of dermatology practice in developing nations in the shadow
of COVID-19: Lessons learnt from the pandemic.
Kumar S(1)(2), Bishnoi A(2), Vinay K(2).
Author information:
(1)Department of Dermatology, Venereology and Leprosy, All India Institute of
Medical Sciences, Rishikesh, India.
(2)Department of Dermatology, Venereology and Leprology, Postgraduate Institute
of Medical Education and Research, Chandigarh, India.
At present, routine dermatology practices stay mostly disrupted worldwide owing
to the ongoing COVID-19 pandemic. However, dermatology services need to be
resumed in future and dermatologists especially in developing countries face a
mammoth task of devising plans to tackle the upcoming surge of patients while
still maintaining the precautions to avoid risk of infection to health care
workers and our patients. Teledermatology practice is a viable alternative and
there is need of starting functioning teledermatology centers at primary health
care centers and training health care workers in telemedicine. Several steps
like increasing the working hours of outpatient clinics, posting dermatologists
and health staffs in shifts, encouraging online registration and payment,
providing time slots to patients should be taken to prevent overcrowding at
outpatient departments in hospitals of developing countries like India where the
usual patient turnover during summers maybe around 600 to 800 per day. Once
diagnosed by the dermatologist, a subsequent meticulous use of teledermatology
can limit the number of follow-up visits. To avoid student gatherings, the
undergraduate and postgraduate teaching schedule should be replaced by online or
virtual teaching in form of webinars and video conferencing. Above all, intense
upgradation of health care infrastructure, recruitment, training of new health
care staffs on mass level and huge investment in health care sector is required
in all the developing countries.
© 2020 Wiley Periodicals LLC.
DOI: 10.1111/dth.13472
PMCID: PMC7261977
PMID: 32347612
Conflict of interest statement: The authors declare no conflicts of interest.
1. J Dermatolog Treat. 2020 May 4:1-9. doi: 10.1080/09546634.2020.1762843. [Epub
ahead of print]
Inpatient Teledermatology During the COVID-19 Pandemic.
Rismiller K(1), Cartron AM(2), Trinidad JCL(1).
Author information:
(1)Division of Dermatology, Department of Internal Medicine, The Ohio State
University Wexner Medical Center, Columbus, Ohio, USA.
(2)Department of Dermatology, University of Maryland School of Medicine,
Baltimore, MD, USA.
DOI: 10.1080/09546634.2020.1762843
PMID: 32364809
2. J Am Acad Dermatol. 2020 May 4. pii: S0190-9622(20)30776-3. doi:
10.1016/j.jaad.2020.04.154. [Epub ahead of print]
The COVID-19 crisis: A unique opportunity to expand dermatology to underserved
populations.
Ashrafzadeh S(1), Nambudiri VE(2).
Author information:
(1)Harvard Medical School, Boston, Massachusetts, USA; Department of Dermatology,
Brigham and Women's Hospital, Boston, Massachusetts, USA.
(2)Department of Dermatology, Brigham and Women's Hospital, Boston,
Massachusetts, USA. Electronic address: vnambudiri@bwh.harvard.edu.
DOI: 10.1016/j.jaad.2020.04.154
PMCID: PMC7198179
PMID: 32380217
3. Australas J Dermatol. 2020 May 3. doi: 10.1111/ajd.13301. [Epub ahead of print]
Practice guidelines for teledermatology in Australia.
Abbott LM(1)(2), Miller R(1), Janda M(3), Bennett H(1), Taylor M(4), Arnold C(1),
Shumack S(1), Soyer HP(5), Caffery LJ(5).
Author information:
(1)The Australasian College of Dermatologists, Sydney, New South Wales,
Australia.
(2)Sydney Law School, University of Sydney, Sydney, New South Wales, Australia.
(3)Centre for Health Services Research, The University of Queensland, St Lucia,
Queensland, Australia.
(4)Centre for Online Health, Centre for Health Services Research, The University
of Queensland, St Lucia, Queensland, Australia.
(5)The University of Queensland Diamantina Institute, Woolloongabba, Queensland,
Australia.
Despite the potential of teledermatology to increase access to dermatology
services and improve patient care, it is not widely practised in Australia. In an
effort to increase uptake of teledermatology by Australian dermatologists and
support best practice, guidelines for teledermatology for the Australian context
have been developed by The University of Queensland's Centre for Online Health in
collaboration with The Australasian College of Dermatologists' E-Health
Committee. The guidelines are presented in two sections: 1. Guidelines and 2.
Notes to support their application in practice, when feasible and appropriate.
Content was last updated March 2020 and includes modalities of teledermatology;
patient selection and consent; imaging; quality and safety; privacy and security;
communication; and documentation and retention of clinical images. The guidelines
educate dermatologists about the benefits and limitations of telehealth while
articulating how to enhance patient care and reduce risk when practicing
teledermatology.
© 2020 The Authors. Australasian Journal of Dermatology published by John Wiley &
Sons Australia, Ltd on behalf of Australasian College of Dermatologists.
DOI: 10.1111/ajd.13301
PMID: 32363572
4. Int J Med Inform. 2020 Mar 13;139:104118. doi: 10.1016/j.ijmedinf.2020.104118.
[Epub ahead of print]
Teleoncology for children with cancer: A scoping review on applications and
outcomes.
Kermani F(1), Orooji A(2), Sheikhtaheri A(3).
Author information:
(1)Department of Health Information Management, School of Health Management and
Information Sciences, Iran University of Medical Sciences, Tehran, Iran.
(2)School of Medicine, North Khorasan University of Medical Science (NKUMS),
North Khorasan, Iran.
(3)Health Management and Economics Research Center, Department of Health
Information Management, School of Health Management and Information Sciences,
Iran University of Medical Sciences, Tehran, Iran. Electronic address:
BACKGROUND AND OBJECTIVES: Teleoncology can be used to reduce the limitations due
to the lack of access to specialists, inadequate resources and training, and
reducing unnecessary travels and arising of the costs. The purpose of this study
was to review the literatures to identify and classify the areas of application
and outcomes of using teleoncology in diagnosis, management, and treatment of
children with cancer.
METHODS: This scoping review of the published literatures was conducted by
searching the Web of Science, PubMed/Medline, Scopus, and Cochrane Library
databases in October 2019. Studies investigated telemedicine in diagnosis,
management, and treatment of cancer in children were also included. We identified
and classified different applications and the reported outcomes of this
technology.
RESULTS: In this study, 1834 articles were retrieved, and after removing the
unrelated and duplicated articles, 20 articles were reviewed ultimately. We found
that, teleoncology services were provided to the patients with cancer, their
parents, and nurses in various clinical fields such as telepathology, telemental
care (telepsychology), teleneurology, teledermatology, telehematology, and
teleophthalmology. The findings also showed that, the outcomes of using
telemedicine in children with cancer can be classified into six general
categories (five primary and 14 secondary outcomes). Primary outcomes including
diagnosis accuracy, reduced costs as well as mortality and secondary outcomes
consist of improved relationship and training, better care management,
satisfaction, and workload.
CONCLUSION: The use of telemedicine for children with cancer is growing, and
there is a tendency for using this technology for families and clinical staff.
Providing teleoncology services to children with cancer may improve diagnosis
accuracy and reduce the cost and mortality rate. Also, better care management,
appropriate relationships and training, increased satisfaction, and decreased
workload may be achieved.
Copyright © 2020 Elsevier B.V. All rights reserved.
DOI: 10.1016/j.ijmedinf.2020.104118
PMID: 32353751
5. Telemed J E Health. 2020 Apr 27. doi: 10.1089/tmj.2020.0013. [Epub ahead of
print]
Implementing Teledermatology for Rural Veterans: An Evaluation Using the RE-AIM
Framework.
Peracca SB(1), Jackson GL(2)(3), Lamkin RP(4), Mohr DC(4)(5), Zhao M(4), Lachica
O(1), Prentice JC(4)(6), Grenga AM(7), Gifford A(4), Chapman JG(2), Weinstock
MA(7)(8)(9), Oh DH(1)(8)(10).
Author information:
(1)Dermatology Service, San Francisco Veterans Affairs Health Care System, San
Francisco, California, USA.
(2)Center of Innovation to Accelerate Discovery and Practice Transformation
(ADAPT), Durham Veterans Affairs Health Care System, Durham, North Carolina, USA.
(3)Department of Population Health Sciences and Division of General Internal
Medicine, Department of Medicine, Duke University, North Carolina, USA.
(4)Center for Healthcare Organization and Implementation Research (CHOIR),
Veterans Affairs Boston Health Care System, Boston, Massachusetts, USA.
(5)Department of Health Law, Policy and Management, School of Public Health,
Boston University, Boston, Massachusetts, USA.
(6)Department of Psychiatry, School of Medicine, Boston University,
Massachusetts, USA.
(7)Providence VA Medical Center, Providence, Rhode Island.
(8)Office of Connected Care, Veterans Health Administration, Washington, District
of Columbia, USA.
(9)Dermatoepidemiology Unit, Departments of Dermatology and Epidemiology, Brown
University, Providence, Rhode Island, USA.
(10)Department of Dermatology, University of California at San Francisco, San
Francisco, California, USA.
Introduction: Few systematic evaluations of implementing teledermatology programs
in large health care systems exist. We conducted a longitudinal evaluation of a
U.S. Department of Veterans Affairs (VA) initiative to expand asynchronous
consultative teledermatology services for rural veterans. Methods: The reach,
effectiveness, adoption, implementation, and maintenance framework guided the
evaluation, which included analysis of quantitative VA administrative data as
well as an online survey completed by participating facilities. The first 2 years
of the program were compared with the year before the start of funding. Results:
Sixteen hub facilities expanded teledermatology's reach over the 2-year period,
increasing the number of referral spoke sites, unique patients served, and
teledermatology encounters. Effectiveness was reflected as teledermatology
constituted an increasing fraction of dermatology activity and served more
remotely located patients. Adoption through defined stages of implementation
progressed as facilities engaged in a variety of strategies to enhance
teledermatology implementation, and facilitators and barriers were identified.
Program maintenance was assessed by Program Sustainability Index scores, which
reflected the importance of executive support, and ongoing concerns about
staffing and longitudinal funding. Discussion: Enabling hubs to create solutions
that best fit their needs and culture likely increased reach and effectiveness.
Important facilitators included organizational leadership and encouraging
communication between stakeholders before and during the intervention.
Conclusions: A systematic analysis of teledermatology implementation to serve
rural sites in VA documented a high degree of implementation and sustainability
as well as areas for improvement.
DOI: 10.1089/tmj.2020.0013
PMID: 32343924
6. PLoS One. 2020 Apr 27;15(4):e0232131. doi: 10.1371/journal.pone.0232131.
eCollection 2020.
Teledermatology in Norway using a mobile phone app.
Rizvi SMH(1)(2), Schopf T(3), Sangha A(2), Ulvin K(2), Gjersvik P(4).
Author information:
(1)Department of Dermatology, Oslo University Hospital, Oslo, Norway.
(2)Askin AS, Oslo, Norway.
(3)National Centre for e-Health Research, University Hospital Northern Norway,
Tromsø, Norway.
(4)Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Rashes, ulcers and skin lesions are well suited for telemedicine. We have
developed a smartphone app, the first of its kind in Norway, where a referring
physician can write a short medical history and take clinical and dermatoscopic
photographs with a smartphone, which is then sent to and evaluated by a
dermatologist. In the period from June 1st, 2017, to September 1st, 2019,
clinical information and photographs of rash and skin lesions from 171 patients
were sent by 40 primary care and nursing home physicians via the smartphone app
to four dermatologists for diagnosis and therapeutic advice. A wide range of
dermatological conditions were diagnosed, most commonly chronic ulcers (17%),
eczema (15%) and pigmented lesions (13%). Assessed later by a dermatologist,
referral for regular consultations with a specialist was avoided in 119 patients
(70%). Sixteen patients (9%) were recommended a regular consultation with a
dermatologist; information for prioritization in the specialist healthcare
service was then provided. In 36 patients (21%), further measures by the
referring physician were recommended. Our experience indicates that many ordinary
consultations on rash, ulcers and skin lesions in the specialist healthcare
services can be avoided when using the smartphone app.
DOI: 10.1371/journal.pone.0232131
PMCID: PMC7185702
PMID: 32339203
Conflict of interest statement: SMHR, AS and KU founded and are shareholders in
Askin AS (www.askin.no) of which TS is a partner. PG has no conflict of interest.
The commercial affiliation does not alter our adherence to PLOS ONE policies on
sharing data and materials.
7. J Am Acad Dermatol. 2020 Apr 22. pii: S0190-9622(20)30696-4. doi:
10.1016/j.jaad.2020.04.080. [Epub ahead of print]
Teledermatology in the Wake of COVID-19: Advantages and Challenges to Continued
Care in a Time of Disarray.
Gupta R(1), Ibraheim MK(2), Doan HQ(3).
Author information:
(1)School of Medicine, Baylor College of Medicine, Houston, TX, USA. Electronic
address: rohit.gupta@bcm.edu.
(2)The University of Texas McGovern Medical School, Houston, TX, USA.
(3)Department of Dermatology, Division of Internal Medicine, The University of
Texas MD Anderson Cancer Center, Houston, TX, USA.
DOI: 10.1016/j.jaad.2020.04.080
PMCID: PMC7175895
PMID: 32334056
8. J Med Internet Res. 2020 Apr 21;22(4):e16700. doi: 10.2196/16700.
Benefits of Teledermatology for Geriatric Patients: Population-Based
Cross-Sectional Study.
G Bianchi M(#)(1), Santos A(#)(1), Cordioli E(#)(1).
Author information:
(1)Telemedicine, Hospital Israelita Albert Einstein, São Paulo, Brazil.
(#)Contributed equally
BACKGROUND: Teledermatology is a health care tool that has been increasingly used
around the world, mostly because dermatology has an emphasis on visual diagnosis.
Many studies have shown that access to specialized care improves using
teledermatology, which provides accurate diagnosis and reduces the time taken for
treatment, with high patient satisfaction. As the population around the world
grows old, there will be even more demand for dermatologists in years to come. It
is essential to know which are the most prevalent skin conditions in the primary
care population and if they can be addressed through teledermatology.
OBJECTIVE: Our main goal was to evaluate the proportion of lesions in individuals
aged 60 years and older that could be managed using teledermatology in
conjunction with primary care physicians. Second, we aimed to assess the most
frequent skin lesions, the most common treatments provided to patients, and the
distribution and causes of referrals made by the teledermatologists.
METHODS: This was a retrospective cohort study from July 2017 to July 2018 in São
Paulo, Brazil. We included 6633 individuals aged 60 years and older who presented
with 12,770 skin lesions. Teledermatologists had three options to refer patients:
(1) to undergo biopsy directly, (2) to an in-person dermatologist visit, and (3)
back to the primary care physician with the most probable diagnosis and
treatment.
RESULTS: Teledermatology managed 66.66% (8408/12614) of dermatoses with the
primary care physician without the need for an in-presence visit; 27.10%
(3419/12614) were referred to dermatologists, and 6.24% (787/12614) directly to
biopsy. The most frequent diseases were seborrheic keratosis, solar lentigo,
onychomycosis, melanocytic nevus, benign neoplasms, actinic keratosis, epidermoid
cyst, xerosis, leucoderma, and wart, with significant differences between sexes.
Malignant tumors increased with age and were the leading cause for biopsies,
while infectious skin conditions and pigmentary disorders decreased. Emollient
was the most frequent treatment prescribed, in 31.88% (909/2856) of the cases.
CONCLUSIONS: Teledermatology helped to treat 67% of the dermatoses of older
individuals, addressing cases of minor complexity quickly and conveniently
together with the primary care physician, thus optimizing dermatological
appointments for the most severe, surgical, or complex diseases. Teledermatology
does not aim to replace a face-to-face visit with the dermatologist; however, it
might help to democratize dermatological treatment access for patients and
decrease health care expenses.
©Mara G Bianchi, Andre Santos, Eduardo Cordioli. Originally published in the
Journal of Medical Internet Research (http://www.jmir.org), 21.04.2020.
DOI: 10.2196/16700
PMCID: PMC7201316
PMID: 32314966
9. Mil Med. 2020 Apr 20. pii: usz479. doi: 10.1093/milmed/usz479. [Epub ahead of
print]
Synchronous Teledermoscopy in Military Treatment Facilities.
Day WG(1), Shrivastava V(2), Roman JW(2).
Author information:
(1)Internal Medicine Intern, Naval Medical Center Portsmouth, 620 John Paul Jones
Cir, Portsmouth, VA 23708.
(2)Department of Dermatology, Naval Medical Center Portsmouth, 620 John Paul
Jones Cir, Portsmouth, VA 23708.
Sustained demand for dermatologic care throughout military medicine, in
conjunction with increasing dermatologic provider shortages, has led to increase
use of teledermatology in military treatment facilities (MTFs). Initially used to
aid in the differentiation of suspicious melanocytic lesions, dermoscopy has
found increasing clinical utility in an expanding realm of general dermatologic
conditions. We demonstrate the use of synchronous teledermoscopy within a remote
MTF by repurposing webcam technology already available at most MTFs. Two patients
were seen in clinic at a remote naval primary care clinic with limited
subspecialties. Once written consent was retrieved, an on-site dermatologist
evaluated each patient and performed a history and skin exam with dermoscopy.
Synchronous consultations were conducted with the Global Med Cart (GlobalMed(R)
Clinical Access Station with TotalExam(R) 3 HDUSB camera), and Cisco webcam video
jabber (Cisco TelePresence PrecisionHD USB Camera part number TTC8-03). The
patients then underwent individual synchronous teledermatology consultations with
an off-site U.S. Navy dermatologist located in the continental United States. The
methodology for the consultation involved the use of a standard dermatoscope and
jabber webcam. Two synchronous teledermatology consultations were completed
successfully on patients in MTFs with limited subspecialty capabilities. Both
cases, with two lesions of concern per case, had 100% concordance between the
on-site and teleconsulted dermatologist. Through observing inter-rater agreements
between the on-site and remote dermatologists, this small study demonstrates a
novel application of technology readily available at most MTFs.
© The Author(s) 2020. Published by Oxford University Press on behalf of the
Association of Military Surgeons of the United States. All rights reserved. For
permissions, please e-mail: journals.permissions@oup.com.
DOI: 10.1093/milmed/usz479
PMID: 32307547
10. J Am Acad Dermatol. 2020 Apr 16. pii: S0190-9622(20)30661-7. doi:
10.1016/j.jaad.2020.04.048. [Epub ahead of print]
Teledermatology in the Era of COVID-19: Experience of an Academic Department of
Dermatology.
Perkins S(1), Cohen JM(2), Nelson CA(2), Bunick CG(2).
Author information:
(1)Department of Dermatology, Yale University, New Haven, CT, 06520. Electronic
address: sara.perkins@yale.edu.
(2)Department of Dermatology, Yale University, New Haven, CT, 06520.
DOI: 10.1016/j.jaad.2020.04.048
PMCID: PMC7162755
PMID: 32305442
11. Clin Exp Dermatol. 2020 Apr 18. doi: 10.1111/ced.14245. [Epub ahead of print]
Telemedicine and support groups in order to improve the adherence to treatment
and health related quality of life in patients affected by inflammatory skin
conditions during COVID-19 emergency.
Marasca C(1), Ruggiero A(1), Fontanella G(1), Ferrillo M(1), Fabbrocini G(1),
Villani A(1).
Author information:
(1)Section of Dermatology, Department of Clinical Medicine and Surgery,
University of Naples Federico II, Napoli, Italy.
We have read with great interest the article by Deepak et al. which reported the
measures applied during the COVID-19 emergency in order to answer to the request
of consultations. Particularly they described the growing importance that
telemedicine is having during this emergency, focusing on the use of mobile
technology (particularly the use of WhatsApp) as a method to communicate via text
messages, voice messages, photos and videos, which is rapidly expanding within
the field of telemedicine.
This article is protected by copyright. All rights reserved.
DOI: 10.1111/ced.14245
PMID: 32304587
12. Clin Exp Dermatol. 2020 Apr 17. doi: 10.1111/ced.14244. [Epub ahead of print]
Secure communication conduits during COVID19 lockdown.
Black SM(1), Ali FR(2).
Author information:
(1)Medical Sciences Division, University of Oxford, Oxford, UK.
(2)Vernova Healthcare Community Interest Company, Macclesfield, UK.
We commend Deepak and colleagues in highlighting the virtues of instant messaging
tools such as WhatsApp during the COVID-19 crisis1 . Whilst WhatsApp's advantages
include being highly intuitive, widely used and accessible, there are concerns
among clinicians about its use, as well as that of other commercially available
communications apps. These include the loss of anonymity to patients, the need to
reveal their personal telephone number as well questions over privacy and data
security.
This article is protected by copyright. All rights reserved.
DOI: 10.1111/ced.14244
PMID: 32302418
13. Dermatol Online J. 2019 Nov 15;25(11). pii: 13030/qt6xh9p2nn.
Implementation of a patient-assisted teledermatology model in the Veteran Health
Administration.
Fortugno AP, Dellavalle RP(1).
Author information:
(1)Department of Dermatology, University of Colorado School of Medicine, Aurora,
CO Dermatology Service, U.S. Department of Veterans Affairs, Eastern Colorado
Health Care System, Aurora, CO Department of Epidemiology, Colorado School of
Public Health, University of Colorado Anschutz Medical Campus, Aurora, CO.
Owing to the inherently visual nature of the field of dermatology, advances in
imaging and communication technology have resulted in wide-spread application of
teledermatology since its introduction in the mid-1990s. In the last 20 years,
studies have repetitively shown that teledermatology provides effective and
efficient quality care for patients. It also increases access to underserved
patients and reduces traveling costs, wait times, and unnecessary referrals. In
this letter the authors seek to analyze implementation of a direct patient to
dermatologist model in a Veteran Health Administration (VHA) patient population,
referred to as patient-assisted teledermatology. This population is largely over
the age of 65 and a significant portion are either without internet or have the
minimum technology necessary to participate in the studied model. Owing to these
observations and personal experiences, the authors found the implementation
process of a patient-assisted model to be challenging in this population.
PMID: 32045144 [Indexed for MEDLINE]
14. JAAD Case Rep. 2020 Jan 30;6(2):141-143. doi: 10.1016/j.jdcr.2019.11.006.
eCollection 2020 Feb.
A suspected hedgehog dermatosis diagnosed via store and forward teledermatology.
Said JT(1), Stavert R(2).
Author information:
(1)Harvard Medical School, Boston, Massachusetts.
(2)Department of Dermatology, Cambridge Health Alliance, Harvard Medical School,
Boston, Massachusetts.
DOI: 10.1016/j.jdcr.2019.11.006
PMCID: PMC7000437
PMID: 32042872
15. J Am Acad Dermatol. 2020 Feb 5. pii: S0190-9622(20)30151-1. doi:
10.1016/j.jaad.2020.01.065. [Epub ahead of print]
Clinical effectiveness and cost-effectiveness of teledermatology: Where are we
now, and what are the barriers to adoption?
Wang RH(1), Barbieri JS(2), Nguyen HP(3), Stavert R(4), Forman HP(5), Bolognia
JL(6), Kovarik CL(7); Group for Research of Policy Dynamics in Dermatology.
Author information:
(1)University of Pennsylvania Perelman School of Medicine, Philadelphia,
Pennsylvania.
(2)Department of Dermatology, University of Pennsylvania Perelman School of
Medicine, Philadelphia, Pennsylvania. Electronic address:
john.barbieri@pennmedicine.upenn.edu.
(3)Department of Dermatology, Emory University School of Medicine, Atlanta,
Georgia.
(4)Department of Dermatology, Beth Israel Deaconess Medical Center, Boston,
Massachusetts.
(5)Department of Public Health (Health Policy), Economics, and Management, Yale
University, New Haven, Connecticut.
(6)Department of Dermatology, Yale School of Medicine, New Haven, Connecticut.
(7)Department of Dermatology, University of Pennsylvania Perelman School of
Medicine, Philadelphia, Pennsylvania.
There has been rapid growth in teledermatology over the past decade, and
teledermatology services are increasingly being used to support patient care
across a variety of care settings. Teledermatology has the potential to increase
access to high-quality dermatologic care while maintaining clinical efficacy and
cost-effectiveness. Recent expansions in telemedicine reimbursement from the
Centers for Medicare & Medicaid Services (CMS) ensure that teledermatology will
play an increasingly prominent role in patient care. Therefore, it is important
that dermatologists be well informed of both the promises of teledermatology and
the potential practice challenges a continuously evolving mode of care delivery
brings. In this article, we will review the evidence on the clinical and
cost-effectiveness of teledermatology and we will discuss system-level and
practice-level barriers to successful teledermatology implementation as well as
potential implications for dermatologists.
Copyright © 2020 American Academy of Dermatology, Inc. Published by Elsevier Inc.
All rights reserved.
DOI: 10.1016/j.jaad.2020.01.065
PMID: 32035106
16. Clin Exp Dermatol. 2020 Feb 7. doi: 10.1111/ced.14191. [Epub ahead of print]
Patient satisfaction with a new skin cancer teledermatology service.
Nicholson P(1), Macedo C(1), Fuller C(1), Thomas L(1).
Author information:
(1)Dermatology Department, Chelsea and Westminster Hospital NHS Foundation Trust,
London, UK.
BACKGROUND: Rising numbers of two-week-wait (2WW) skin cancer referrals have
caused increasing pressure on UK dermatology departments. Initiatives to address
this include teledermatology. Previous studies have indicated good patient
acceptability but most have focused on general dermatology rather than skin
cancer referrals, and have taken place in rural settings, where teledermatology
may be preferable.
AIM: To evaluate patient satisfaction of teledermatology 2WW services in a
London-based tertiary National Health Service (NHS) setting.
METHODS: A literature search was performed and a patient satisfaction survey was
designed to evaluate: (i) ease of completing a questionnaire about the skin
lesion; (ii) lifestyle impact; (iii) preferences regarding electronic data
collection and communication of results; and (iv) confidence in the service. A
five-point Likert scale was used to assess responses. The study took place over a
20-week period.
RESULTS: Over half (51%; n = 31 of 60 patients) were female; 78% (47) were aged
≤ 55 years and 65% (39) were Caucasian. Over 80% (49) would recommend the
service, and the majority felt confident with the teledermatology model. Overall,
patients would be happy to complete electronic questionnaires and receive results
electronically, with younger patients being more amenable to this. Patients with
better health status, those of younger age and those with less frequent visits to
a dermatologist were more accepting of teledermatology.
CONCLUSION: To our knowledge, this is the first comprehensive study evaluating
patient satisfaction with teledermatology specifically for 2WW referrals in an
NHS setting. As skin cancer referrals increase, dermatology departments must
adjust. Patient involvement and feedback is paramount in implementing and
expanding teledermatology services.
© 2020 British Association of Dermatologists.
DOI: 10.1111/ced.14191
PMID: 32031275
17. J Eur Acad Dermatol Venereol. 2020 Feb 7. doi: 10.1111/jdv.16275. [Epub ahead of
print]
Diagnostic accuracy and interobserver concordance: teledermoscopy of 600
suspicious skin lesions in Southern Denmark.
Vestergaard T(1)(2), Prasad SC(1), Schuster A(1), Laurinaviciene R(1), Andersen
MK(3), Bygum A(1).
Author information:
(1)Department of Dermatology and Allergy Centre, Odense University Hospital,
Odense, Denmark.
(2)OPEN, Odense Patient data Explorative Network, Odense University Hospital,
Odense, Denmark.
(3)Audit Project Odense, Research Unit of General Practice, University of
Southern Denmark, Odense, Denmark.
BACKGROUND: Skin cancer incidences are increasing and early diagnosis, especially
of malignant melanoma, is crucial. Teledermatology including teledermoscopy (TDS)
can be used to triage referrals of suspicious skin lesions, however, this is not
currently recommended in Denmark.
OBJECTIVES: To evaluate diagnostic accuracy, sensitivity, specificity and
interobserver concordance of TDS, and to evaluate the number of incidental
lesions potentially missed by TDS.
METHODS: Fifty general practices were invited to send images of suspicious skin
lesions for evaluation using smartphone TDS. Simultaneously, the patient was
referred for a face-to-face (FTF) consultation. Images for TDS were independently
evaluated by two dermatologists; a third dermatologist performed the FTF
consultation. Diagnosis, management plan and level of diagnostic confidence were
noted. For TDS photo quality was rated, and for FTF any incidental findings were
described.
RESULTS: Six hundred lesions in 519 patients were included. The diagnostic
accuracy was significantly higher on FTF evaluation than on TDS (P < 0.01).
However, this was associated with a significant difference in specificity
(P ≤ 0.012) whereas no significant difference was found in sensitivity. The
concordance between FTF and TDS, and the interobserver concordance of two TDS
evaluations was moderate to substantial (AC1 = 0.57-0.71). Incidental melanomas
were found in 0.6% of patients on FTF evaluation, adding an extra 13% of
melanomas. However, on TDS these patients' photographed lesions all warranted FTF
follow-up, where these melanomas would have been identified.
CONCLUSION: In this large prospective study, no significant difference in
sensitivity was observed between FTF and TDS, but specificity was lower on TDS
than FTF. Taking management plans into account, we would, however, potentially
have dismissed 2 of 23 melanomas, if only TDS had been used for assessment. One
of these was a melanoma located on the scalp, an anatomic region less suitable
for TDS.
© 2020 European Academy of Dermatology and Venereology.
DOI: 10.1111/jdv.16275
PMID: 32031277